Less than 10% of South Africans have gotten at least one dose of the Covid-19 vaccine, indicating a roadblock in the government’s effort to vaccinate two-thirds of the population.
According to a survey, the majority of South Africans are unlikely to get vaccinated against coronavirus illness (Covid-19), and nearly half feel praying is more effective against the virus. While 21% of the 1,600 participants thought prayer and vaccines were equally beneficial in reducing coronavirus transmission, only a quarter thought vaccines were more effective than prayer.
South Africans who are poor and under the age of 35 are the most resistant to be vaccinated. Half of those with no formal education, on the other hand, were more likely to get vaccinated than those with at least a primary education. People in urban regions were less willing to get vaccinated than those in rural areas.
The survey, performed by Afrobarometer, found that less than 10% of the South African population had gotten at least one dose of the Covid-19 vaccine, highlighting a roadblock in the government’s aim to vaccinate two-thirds of the population.
According to the survey, South Africans believe they are well-informed on Covid-19, but they don’t trust the government to ensure that the vaccines are safe.
The study, which took place in May and June, has a margin of error of 2.5 percentage points, according to Afrobarometer.
Over 2.4 million Covid-19 cases have been reported in South Africa, with over 70,000 deaths. While around 7 million people have received at least one dose of the Covid-19 vaccination, only roughly 3 million have received the entire dose.
South Africa’s fatal second Covid wave was caused by the Beta type of coronavirus, which was initially discovered there.
The Beta version demonstrated substantial antibody escape in patients who received the AstraZeneca Covid-19 vaccination, according to research. Following the findings of the trial, the South African government decided to sell doses of Covishield, a version of the AstraZeneca Covid-19 vaccine manufactured by the Serum Institute of India, to the African Union.